MULTIPLE MYELOMA IN RELAPSE
Clinical trials for MULTIPLE MYELOMA IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA IN RELAPSE trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World check on promising myeloma drug combos
Disease control CompletedThis study observed how well patients with relapsed multiple myeloma stuck with their prescribed treatment in real-world clinics. It looked at three different drug combinations, all containing carfilzomib, to see how consistently patients took their medicine and how they fared. T…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New combo tested for Tough-to-Treat blood cancer
Disease control CompletedThis early-stage study aimed to find a safe dose for a new three-drug combination (ibrutinib, lenalidomide, and dexamethasone) for adults with multiple myeloma that has returned or stopped responding to prior treatments. The main goal was to check for serious side effects and det…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC